Mouth Diseases
Diseases involving the MOUTH.
Subtype terms (32)
More specific conditions that are subtypes of Mouth Diseases in the MeSH hierarchy.
- Behcet Syndrome
49 drugs (38 approved, 11 experimental)
- Bell Palsy
7 drugs (6 approved, 1 experimental)
- Burning Mouth Syndrome
28 drugs (22 approved, 6 experimental)
- Candidiasis, Oral
29 drugs (16 approved, 13 experimental)
- Dry Socket
17 drugs (6 approved, 11 experimental)
- Facial Hemiatrophy
2 drugs experimental
- Facial Nerve Diseases
2 drugs approved
- Facial Paralysis
8 drugs approved
- Focal Epithelial Hyperplasia
- Granulomatosis, Orofacial
1 drug approved
- Hemifacial Spasm
6 drugs (5 approved, 1 experimental)
- Leukoedema, Oral
- Lichen Planus, Oral
67 drugs (31 approved, 36 experimental)
- Lip Diseases
7 drugs (6 approved, 1 experimental)
- Ludwig's Angina
2 drugs approved
- Melkersson-Rosenthal Syndrome
- Mouth Abnormalities
1 drug approved
- Mouth, Edentulous
1 drug approved
- Mouth Neoplasms
102 drugs (60 approved, 42 experimental)
- Mucositis
134 drugs (76 approved, 58 experimental)
- Noma
- Oral Fistula
- Oral Hemorrhage
4 drugs approved
- Oral Manifestations
8 drugs (5 approved, 3 experimental)
- Oral Submucous Fibrosis
17 drugs (10 approved, 7 experimental)
- Oral Ulcer
25 drugs (15 approved, 10 experimental)
- Periodontal Diseases
108 drugs (46 approved, 62 experimental)
- Ranula
- Salivary Gland Diseases
11 drugs (3 approved, 8 experimental)
- Stomatitis
114 drugs (58 approved, 56 experimental)
- Tongue Diseases
2 drugs (1 approved, 1 experimental)
- Tuberculosis, Oral
Drugs by status
Approved for this indication (2)
Phase 4 trials (2)
Phase 3 trials (4)
Phase 2 trials (3)
Phase 1 trials (2)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (10)
- Sinovac Biotech Co., Ltd
- Capital Medical University
- Fudan University
- Government of China
- China National Biotec Group Co., Ltd
- Weihai Rensheng Pharmacy
- Wuhan Institute of Biological Products Co., Ltd
- Chinese Academy of Medical Sciences
- Dongguan Municipal Center for Disease Control and Prevention
- Guangdong Provincial Center for Disease Control and Prevention
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (16)
- RxKinetix
- Harvard University
- Ho Chi Minh City University of Medicine and Pharmacy
- McMaster University
- University of Ottawa
- University of South Florida
- University of Alberta
- University of California, Los Angeles
- University of Connecticut
- International Center for Diarrheal Disease Research
- University of Oxford
- University of Texas at Houston
- Medical University of Ohio
- Commonwealth ENT, Louisville, KY
- Tropical Diseases Hospital, Ho Chi Minh City
- University of Texas, Austin
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (15)
- Qingfeng Pharmaceutical Group
- Fundacio Salut i Envelliment UAB
- Anhui Medical University
- China Academy of Chinese Medical Sciences
- Guangxi Medical University
- Peking University
- Mutuam
- Anhui College of Traditional Chinese Medicine
- Tianjin Medical University
- Handan Maternal and Child Health Care Hospital
- Jiangxi Children's Hospital
- Chengdu University of Traditional Chinese Medicines
- An'Hui Chinese Medical College
- Tangshan infectious disease hospital
- Tianjin Zhongshenghaitian Pharmaceutical Co. Ltd.